Phase II, double-blinded, randomised, placebo-controlled study to determine the safety, preliminary efficacy and pharmacokinetics of ARG-007 in acute ischaemic stroke patients (SEANCON)

David J. Blacker; Graeme J. Hankey; Meghan Thomas; Tim Phillips; Paul Bailey; Geoffrey Donnan; Jeffrey L. Saver; Samantha South; Neville Knuckey; Bruno Meloni

Phase II, double-blinded, randomised, placebo-controlled study to determine the safety, preliminary efficacy and pharmacokinetics of ARG-007 in acute ischaemic stroke patients (SEANCON)

David J. Blacker, Graeme J. Hankey, Meghan Thomas, Tim Phillips, Paul Bailey, Geoffrey Donnan, Jeffrey L. Saver, Samantha South, Neville Knuckey, Bruno Meloni

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Pages (from-to)	46-46
Number of pages	1
Journal	International Journal of Stroke
Volume	18
Issue number	2
Publication status	Published - Aug 2023

Cite this

Blacker, D. J., Hankey, G. J., Thomas, M., Phillips, T., Bailey, P., Donnan, G., Saver, J. L., South, S., Knuckey, N., & Meloni, B. (2023). Phase II, double-blinded, randomised, placebo-controlled study to determine the safety, preliminary efficacy and pharmacokinetics of ARG-007 in acute ischaemic stroke patients (SEANCON). International Journal of Stroke, 18(2), 46-46.

@article{9f5347911b5c4068b1deb9c8022a86d5,

title = "Phase II, double-blinded, randomised, placebo-controlled study to determine the safety, preliminary efficacy and pharmacokinetics of ARG-007 in acute ischaemic stroke patients (SEANCON)",

author = "Blacker, {David J.} and Hankey, {Graeme J.} and Meghan Thomas and Tim Phillips and Paul Bailey and Geoffrey Donnan and Saver, {Jeffrey L.} and Samantha South and Neville Knuckey and Bruno Meloni",

year = "2023",

month = aug,

language = "English",

volume = "18",

pages = "46--46",

journal = "International Journal of Stroke",

issn = "1747-4930",

publisher = "Wiley-Blackwell",

number = "2",

}

Phase II, double-blinded, randomised, placebo-controlled study to determine the safety, preliminary efficacy and pharmacokinetics of ARG-007 in acute ischaemic stroke patients (SEANCON). / Blacker, David J.; Hankey, Graeme J.; Thomas, Meghan et al.
In: International Journal of Stroke, Vol. 18, No. 2, 08.2023, p. 46-46.

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

TY - JOUR

T1 - Phase II, double-blinded, randomised, placebo-controlled study to determine the safety, preliminary efficacy and pharmacokinetics of ARG-007 in acute ischaemic stroke patients (SEANCON)

AU - Blacker, David J.

AU - Hankey, Graeme J.

AU - Thomas, Meghan

AU - Phillips, Tim

AU - Bailey, Paul

AU - Donnan, Geoffrey

AU - Saver, Jeffrey L.

AU - South, Samantha

AU - Knuckey, Neville

AU - Meloni, Bruno

PY - 2023/8

Y1 - 2023/8

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uwapure5-25&SrcAuth=WosAPI&KeyUT=WOS:001086630900116&DestLinkType=FullRecord&DestApp=WOS

M3 - Abstract/Meeting Abstract

SN - 1747-4930

VL - 18

SP - 46

EP - 46

JO - International Journal of Stroke

JF - International Journal of Stroke

IS - 2

ER -

Phase II, double-blinded, randomised, placebo-controlled study to determine the safety, preliminary efficacy and pharmacokinetics of ARG-007 in acute ischaemic stroke patients (SEANCON)

Other files and links

Cite this